Ticker Details
BioXcel Therapeutics, Inc.
IPO Date:	March 5, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$34.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 4.24%
Avg Daily Range (30 D):	$0.05 | 2.97%
Avg Daily Range (90 D):	$0.07 | 3.66%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	197
Avg Trade Size (Sh.) (90 D):	207

Institutional Trades
Total Institutional Trades:	908
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$.87M
Avg Institutional Trade (90 D):	$.87M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.56M
Avg Closing Trade (30 D):	$.87M
Avg Closing Trade (90 D):	$.87M
Avg Closing Volume:	4.6K

News

Oct 13, 2025 @ 11:00 AM BioXcel Therapeutics to Ring Nasdaq Closing Bell o... Source: Vimal Mehta, Ph.D.

Sep 18, 2025 @ 11:00 AM BioXcel Therapeutics Regains Compliance with Nasda... Source: Bioxcel Therapeutics, Inc.

Aug 27, 2025 @ 12:00 PM UPDATE -- BioXcel Therapeutics Announces SERENITY ... Source: Bioxcel Therapeutics

Aug 26, 2025 @ 8:00 PM BioXcel Therapeutics To Announce Topline Results f... Source: Bioxcel Therapeutics, Inc.

Aug 18, 2025 @ 11:00 AM BioXcel Therapeutics Announces Positive FDA Pre-sN... Source: Bioxcel Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-9.29	$-2.18	$-2.45
Diluted EPS	$-9.29	$-2.18	$-2.45
Revenue	$.75M	$.1M	$.12M
Gross Profit	$-.21M	$.09M	$.01M
Net Income / Loss	$-68.21M	$-30.91M	$-19.19M
Operating Income / Loss	$-50.67M	$-14.23M	$-15.85M
Cost of Revenue	$.96M	$.01M	$.11M
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Feb 10, 2025	1:16